Your search returned 3 results.

Results
	1.	Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival. [electronic resource] by Luchman, H Artee Stechishin, Owen D M Nguyen, Stephanie A Lun, Xueqing Q Cairncross, J Gregory Weiss, Samuel Producer: 20150709 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation. [electronic resource] by Nguyen, Stephanie A Stechishin, Owen D M Luchman, H Artee Lun, Xueqing Q Senger, Donna L Robbins, Stephen M Cairncross, J Gregory Weiss, Samuel Producer: 20150731 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Oligodendroglioma cell lines containing t(1;19)(q10;p10). [electronic resource] by Kelly, John J P Blough, Michael D Stechishin, Owen D M Chan, Jennifer A W Beauchamp, Desiree Perizzolo, Marco Demetrick, Doug J Steele, Lisa Auer, Roland N Hader, Walter J Westgate, Morgan Parney, Ian F Jenkins, Robert Cairncross, J Gregory Weiss, Samuel Producer: 20120827 In: Neuro-oncology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)